Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 15, 2009, Pages 6220-6225

  Arashiro, Patricia ^a   Eisenberg, Iris ^b   Kho, Alvin T ^c   Cerqueira, Antonia M P ^a   Canovas, Marta ^a   Silva, Helga C A ^d   Pavanello, Rita C M ^a   Verjovski Almeida, Sergio ^a   Kunkel, Louis M ^b   Zatz, Mayana ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Expression profiling; Microarray; Skeletal muscle

Indexed keywords

CHEMOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL; HISTONE; MICRORNA;

ACETYLATION; ADULT; ALLELE; ARTICLE; CHROMOSOME 4Q; COMPARATIVE STUDY; CONTROLLED STUDY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETICS; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SAMPLE; TRANSCRIPTION REGULATION; CASE CONTROL STUDY; CHROMOSOME 4; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 4; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HETEROZYGOTE; HUMANS; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; POLYMORPHISM, GENETIC; TRANSCRIPTION, GENETIC;

EID: 65549085668     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0901573106     Document Type: Article

References (45)

1. Wijmenga C, et al. (1990) Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 336:651-653.
2. van Deutekom JCT, et al. (1993) FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Molec Genet 2:2037-2042.
3. Padberg GW, et al. (1995) On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve 2:S73-S80.
4. Bungener C, Jouvent R, Delaporte C (1998) Psychopathological and emotional deficits in myotonic dystrophy. J Neurol Neurosurg Psychiatry 65:353-356.
5. Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BGM, Bleijenberg G (2007) Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulo-humeral dystrophy, and hereditary motor and sensory neuropathy type I. Acta Neurol Scand 115:265-270.
6. Pandya S, King WM, Tawil R (2008) Facioscapulohumeral dystrophy. Phys Ther 88(1):105-113.
7. Lunt PW, et al. (1995) Phenotypic-genotypic correlation will assist genetic counseling in 4q35- facioscapulohumeral muscular dystrophy. Muscle Nerve 2:S103-S109.
8. Padberg GW, et al. (1995) Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve 2:S81-S84.
9. Zatz M, et al. (1995) High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families. Am J Hum Genet 56(1):99-105.
10. Tonini MMO, et al. (2004) Homozygosity for autosomal dominant facioscapulo-humeral muscular dystrophy (FSHD) does not result in a more severe phenotype. J Med Genet 41(2):e17-e22.
11. Padberg GW, Lunt PW, Koch M, Fardeau M (1991) Diagnostic criteria for facioscapu-lohumeral muscular dystrophy. Neuromuscul Disord 1:231-234.
12. Zatz M, et al. (1998) The facioscapulohumeral muscular dystrophy (FSHD1 ) gene affects males more severly and more frequently than females. Am J Med Genet 77(2):155-161.
13. Tonini MMO, et al. (2004) Asymptomatic carriers and gender differences in facioscapu-lohumeral muscular dystrophy (FSHD). Neuromuscul Disord 14(1):33-38.
14. Deidda G, et al. (1995) Physical mapping evidence for a duplicated region on chromosome 10qter showing high homology with the facioscapulohumeral muscular dystrophy locus on chromosome 4qter. Eur J Hum Genet 3(3):155-167.
15. van Deutekom JCT, et al. (1996) Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counseling and etiology of FSHD1 . Hum Mol Genet 5:1997-2003.
16. Lemmers RJ, et al. (1998) Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis. Hum Mol Genet 7:1207-1214.
17. Tupler R, et al. (1996) Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. J Med Genet 33:366-370.
18. Lemmers RJ, et al. (2007) Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. Am J Hum Genet 81:884-894.
19. van Overveld PGM, et al. (2003) Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 35:315-317.
20. Kowaljow V, et al. (2007) The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord 17:611-623.
21. Dixit M, et al. (2007) DUX4 , a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci USA 104:18157-18162.
22. Hewitt JE, et al. (1994) Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Molec Genet 3:1287-1295.
23. Winokur ST, et al. (1994) The DNA rearrangement associated with facioscapulo-humeral muscular dystrophy involves a heterochromatin-associated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease. Chromosome Res 2:225-234.
24. Gabellini D, Green MR, Tupler R (2002) Inappropriate gene activation in FSHD: A repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110:339-348.
25. Petrov A, et al. (2006) Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts. Proc Natl Acad Sci USA 103:6982-6987.
26. Chen JF, et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38:228-233.
27. Callis TE, Deng Z, Chen JF, Wang DZ (2008) Muscling through the microRNA world. Exp Biol Med 233(2):131-138.
28. Eisenberg I, et al. (2007) Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci USA 104:17016-17021.
29. Cheung VG, et al. (2003) Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 33:422-425.
30. Sharma A, et al. (2005) Assessing natural variations in gene expression in humans by comparing with monozygotic twins using microarrays. Physiol Genomics 21(1):117-123.
31. Osborne RJ, Welle S, Venance SL, Thornton CA, Tawil R (2007) Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology 68:569-577.
32. Celegato B, et al. (2006) Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteom-ics 6:5303-5321.
33. Winokur ST, et al. (2003) Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet 12:2895-2907.
34. Campanaro S, et al. (2002) Gene expression profiling in dysferlinopathies using a dedicated muscle microarray. Hum Mol Genet 11:3283-3298.
35. Bakay M, Zhao P, Chen J, Hoffman EP (2002) A Web-accessible complete transcriptome of normal human and DMD muscle. Neuromuscul Disord 12(S1):S125-S141.
36. Paulick MG, Bertozzi CR (2008) The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins. Biochemistry 47:6991-7000.
37. Freeze HH (2006) Genetic defects in the human glycome. Nat Rev Genet 7:537-551.
38. Anderson RG, Jacobson K (2002) A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296:1821-1825.
39. Bonilla E, Fischbeck K, Schotland DL (1981) Freeze-fracture studies of muscle caveolae in human muscular dystrophy. Am J Pathol 104(2):167-173.
40. Reed P, et al. (2006) Sarcolemmal reorganization in facioscapulohumeral muscular dystrophy. Ann Neurol 59:289-297.
41. Nozaki M, et al. (1999) Developmental abnormalities of glycosylphosphatidylinositol-anchor-deficient embryos revealed by Cre/loxP system. Lab Invest 79(3):193-199.
42. Peterson CL, Laniel MA (2004) Histones and histone modifications. Curr Biol 14:R546-R551.
43. Jiang G, et al. (2003) Testing the position-effect variegation hypothesis for facioscapu-lohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Molec Genet 12:2909-2921.
44. Yang F, Shao C, Vedanarayanan V, Ehrlich M (2004) Cytogenetic and immuno-FISH analysis of the 4q subtelomeric region, which is associated with facioscapulohumeral muscular dystrophy. Chromosoma 112:350-359.
45. Dennis G, Jr, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4(9):R60-R60.11.